RSV Vaccine Candidates Show Promise In Older Adults In Late-Breaking Studies, Results Show

Healio (10/20, Schoen) reports “three late-breaking studies offered a promising glimpse of respiratory syncytial virus vaccines in the pipeline for older adults – including” GlaxoSmithKline’s “RSVPreF3 OA vaccine, which showed an overall vaccine efficacy...